By Christine Wanjiku
There is no consistent evidence that genetically modified (GM) foods cause major human diseases, according to a new scientific review.
The study, published in the journal GM Crops & Food, analyzed decades of epidemiological data and scientific literature to examine whether there is a relationship between genetically modified organisms (GMOs) and illnesses such as cancer, allergies, and reproductive disorders.
“Current evidence does not support consistent causal links between GMO consumption and cancer, reproductive toxicity, allergies, or other chronic diseases,” reads the report.
GM crops are plants whose genetic material has been altered using biotechnology to introduce specific traits such as resistance to pests, diseases, or herbicides. Since their commercial introduction in the mid-1990s, GM crops have become a major component of global agriculture, particularly in countries such as the United States, Brazil, and Argentina.
The researchers reviewed data from international health databases and scientific studies spanning several decades. They examined trends in disease incidence across countries before and after the approval of GMO crops to determine whether health problems increased following their adoption.
“Across countries and disease categories, no consistent temporal relationship was found between GMO approval and changes in disease rates,” the study reported.
According to the analysis, major health conditions—including cancers, metabolic disorders, cardiovascular diseases, and allergies have not shown statistically significant associations with GMO exposure in population-level studies.
International health agencies have also reached similar conclusions. The World Health Organization (WHO) and other global bodies maintain that GM foods currently available on the market have undergone safety assessments and no confirmed adverse health effects have been reported from their consumption.
“Despite this scientific consensus, public concern about GM foods remains widespread. However, these worries are shaped less by the inherent toxicity of the technology itself than by the interplay between changes in agricultural systems and broader social factors,” reads the report.
Since the regulatory authorization and subsequent commercial introduction of GMOs in the 1990s, they have had a profound impact on modern agriculture, public health discourse, and biotechnology development.
During this process, anxieties surrounding GMOs have been amplified not so much by scientific data as by external factors such as increased use of pesticides, environmental associations, regulatory uncertainty and media reporting.
As a result, the perception that “GMOs = risk” has become rooted, and is based less on direct toxicological evidence than on deficits of social trust, shortcomings in risk communication, and ongoing institutional controversies.
“This context means that the GMO safety debate extends beyond the scientific evaluation of biotechnology per se, and constitutes a complex societal issue that is entangled with agricultural management, chemical regulation, and the processes of social consensus-building,” the report reveals.
Globally, the cultivation of GM crops has expanded rapidly over the past two decades. Today, they are grown in about 30 countries and cover more than 200 million hectares of farmland. The most common genetically modified crops include maize, soybean, cotton and canola.
The majority of GM crops are engineered with traits such as herbicide tolerance or insect resistance, allowing farmers to manage weeds and pests more effectively. Supporters argue that these technologies can improve agricultural productivity and reduce the need for certain pesticides. However, critics continue to raise concerns about ecological effects, corporate control of seeds, and long-term health impacts.
The authors of the study acknowledge that research into GMOs is still evolving and say more long-term studies are needed. They recommend future research that uses more precise exposure measurements and long-term health monitoring to better understand potential risks.
